ロード中...
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial
IMPORTANCE: Facial angiofibromas occur in approximately 75% of individuals with tuberous sclerosis complex (TSC), causing substantial morbidity and disfigurement. Current therapies are partially effective, uncomfortable, produce scarring, and need repeating to treat recurrence. OBJECTIVE: To evaluat...
保存先:
| 出版年: | JAMA Dermatol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Medical Association
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6128508/ https://ncbi.nlm.nih.gov/pubmed/29800048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2018.0464 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|